MORRISVILLE, N.C., June 28, 2012 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that it plans to report fiscal-year 2012 financial results on Form 10-K on Tuesday, July 24, 2012. Furthermore, on Wednesday, July 25, 2012, at 11 a.m. EDT, Company President and Chief Financial Officer Michael Jebsen will host a conference call and live webcast to discuss the 2012 financial results and the company’s progress.
